![Pius Maliakal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Pius Maliakal formerly worked at PTC Therapeutics, Inc., as Director-Clinical Science and Plus Therapeutics, Inc., as Vice President-Clinical Operations from 2023 to 2024.
Dr. Maliakal received his doctorate degree from the University of Otago and graduate degree from Nagpur University.
Ehemalige bekannte Positionen von Pius Maliakal
| Unternehmen | Position | Ende |
|---|---|---|
| CERENOME, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2024 |
| PTC THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Pius Maliakal
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
3
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
PTC Therapeutics, Inc.
 PTC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets clinically differentiated medicines for neurodegenerative diseases | Health Technology |
University of Otago
 University of Otago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Plus Therapeutics, Inc.
 Plus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops radio therapeutics products | Health Technology |
Nagpur University
 Nagpur University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
